Abstract
Two data sets of natural antiviral agents including 107 anti-HIV1 and 18 anti-polio molecules were collected and subjected to quantitative structure-activity relationship (QSAR) analyses. A wide variety of molecular descriptors belonging to various structural properties were calculated for each molecule. Multiple linear regression (MLR) based on stepwise variable selection was employed to find the most convenient quantitative models. For each antiviral data set different QSAR models were established in two steps. Firstly, for each type of molecular descriptors separate QSAR analysis was performed, and then a new QSAR model was calculated using the selected descriptors in the first phase. For both types of antiviral data sets significant QSAR models were obtained. The atom-centered fragment descriptors represented the highest impact on the anti-HIV1 activity whereas for anti-polio agents, radial distribution function and three-dimensional MoRSE descriptors showed the most significant influences. Cross-validation and a separate prediction set were used to evaluate the stability and prediction ability of the models. It was found the discovered QSAR models for anti-HIV1 and anti-polio agents could reproduce about 80% and 90% of variances in the antiviral activity data with root mean square error of prediction of 0.421 and 0.171, respectively.
Similar content being viewed by others
References
S.P. Whelan, J.N. Barr, G.W. Wertz, Curr. Top. Microbiol. Immunol. 283 (2004) 61.
T. Das, M. Mathur, A.K. Gupta, G.M. Janssen, A.K. Banerjee, Proc. Natl. Acad. Sci. USA 95 (1998) 1449.
X. Shen, P.S. Masters, Proc. Natl. Acad. Sci. USA 98 (2001) 2717.
J.H. Strauss, E.G. Strauss, Viral RNA replication. With a Little Help from the Host, Science 283 (1999) 802.
J.H. Connor, M.O. McKenzie, G.D. Parks, D.S. Lyles, Virology 362 (2007) 109.
P.J. Hotez, D.H. Molyneux, A. Fenwick, E. Ottesen, S.E. Sachs, J.D. Sachs, Plos Med. 3 (2006) 576.
E. Blignaut, Socio-Med. Asp. Aids/HIV 19 (2007) 532.
C.T. Fang, P.C. Hsiung, C.F. Yu, M.Y. Chen, J.D. Wang, Qual. Life Res. 11 (2002) 753.
S. Yallop, A. Lowth, M.H. Fitzgerald, J. Reid, A. Morelli, Cult. Health Sex. 4 (2002) 431.
J.K. Andrus, K. Banerjee, B.P. Hull, J.C. Smith, I. Mochny, J. Infec. Diseases 175 (1997) S89.
S. Bonu, M. Rani, O. Razum, Health Policy 70 (2004) 327.
C. Kapp, World Health Organization Tackles Polio in the Congo, Lancet 353 (1999) 1949.
A. DerMarderosian, J.A. Beutler, Review of Natural Products, 3th ed., Facts & Comparisons, a Wolters Kluwer Company, Missouri, 2006.
R.M.G. Perez, Pharm. Biol. 41 (2003) 107.
J.S. Driscoll, V.E. Marquez, Stem Cells 12 (1994) 7.
N. Castagnoli, L. Kier, Chem. Biodivers. 2 (2005) 409.
T. Kiss, P. Erdi, Biosystems 86 (2006) 46.
A.R. Ortiz, P. Gomez-Puertas, A. Leo-Macias, P. Lopez-Romero, E. Lopez-Vinas, A. Morreale, M. Murcia, K. Wang, Curr. Top. Med. Chem. 6 (2006) 41.
P.H. Reggio, AAPS J. 8 (2006) E322.
T. Fujita, H. Timmerman, QSAR and Drug Design, New Developments and Applications, 1th ed., Elsevier, Amsterdam, 1995.
C. Hansch, D. Hoekman, H. Gao, Chem. Rev. 96 (1996) 1045.
B. Hemmateenejad, J. Chemometr. 18 (2004) 475.
V. Lozitsky, V. Kuzmin, A. Artemenko, R. Lozytska, A. Fedchuk, Y. Boschenko, T. Gridina, L. Shitikova, L. Mudrik, J.J. Vanden Eynde, E. Muratov, D. Kryzhanovsky, Antivir. Res. 57 (2003) A83.
M. Seierstad, D.K. Agrafiotis, Chem. Biol. Drug Des. 67 (2006) 284.
C. Hansch, P.P. Maloney, T. Fujita, R.M. Muir, Nature 194 (1962) 178.
B. Hemmateenejad, M. Sancholi, J. Chemometr. 21 (2007) 96.
L. Kier, L. Hall, Molecular Structure Description, Academic Press, New York, 1999.
L. Eriksson, E. Johansson, Chemom. Intell. Lab. Syst. 34 (1996) 1.
M.M.C. Ferreira, J. Brazil. Chem. Soc. 13 (2002) 742.
B. Hemmateenejad, R. Miri, M. Jafarpour, M. Tabarzad, A. Foroumadi, QSAR Comb. Sci. 25 (2006) 56.
R. Todeschini, V. Consonni, Handbook of Molecular Descriptors, Wiley-VCH Verlag, Weinheim, 2000.
A.T. Balaban, A. Beteringhe, T. Constantinescu, P.A. Filip, O. Ivanciuc, J. Chem. Inf. Model. 47 (2007) 716.
B. Hemmateenejad, R. Miri, N. Edraki, M. Khoshneviszadeh, A. Shafiee, J. Iran. Chem. Soc. 4 (2007) 182.
M. Shamsipur, R. Ghavami, B. Hemmateenejad, H. Sharghi, QSAR Comb. Sci. 23 (2004) 734.
S. Vilar, E. Estrada, E. Uriarte, L. Santana, Y. Gutierrez, J. Chem. Inf. Model. 45 (2005) 502.
I.R.A. Menezes, J.C.D. Lopes, C.A. Montanari, G. Oliva, F. Pavao, M.S. Castilho, P.C. Vieira, M.T. Pupo, J. Comput.-Aided Mol. Des. 17 (2003) 277.
G. Ramirez-Galicia, R. Garduno-Juarez, B. Hemmateenejad, O. Deeb, S. Estrada-Soto, Chem. Biol. Drug Des. 70 (2007) 143.
F.L. Stahura, J.W. Godden, L. Xue, J. Bajorath, J. Chem. Inf. Comput. Sci. 40 (2000) 1245.
A.D. Wright, R. De Nys, C.K. Angerhofer, J.M. Pezzuto, M. Gurrath, J. Nat. Prod. 69 (2006) 1180.
D.J. Livingstone, D.W. Salt, J. Med. Chem. 48 (2005) 661.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hemmateenejad, B., Javidnia, K., Nematollahi, M. et al. QSAR studies on the antiviral compounds of natural origin. JICS 6, 420–435 (2009). https://doi.org/10.1007/BF03245853
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03245853